
3-D Matrix, Ltd.
7777.TJPXHealthcareMedical - Devices
Latest quote
¥364
+¥5.00 · +1.39%
7777.T company overview
Regular session · JST · Market data may be delayed.
Company profile
Company website3-D Matrix, Ltd. specializes in pioneering self-assembling peptide technology. Its flagship product, PuraMatrix, is an innovative self-assembling peptide hydrogel with diverse applications across medical fields, including regenerative medicine, cell therapy, advanced drug delivery systems, and surgical interventions. This Tokyo-based firm was established in 2004.
- Industry
- Medical - Devices
- Sector
- Healthcare
- Headquarters
- JP
- CEO
- Jun Okada
- Listed since
- Oct 24, 2011
- Employees
- 129
Market position
Day range
Current ¥364
52-week range
Current ¥364
- Open
- ¥375
- Previous close
- ¥359
- Volume
- 1.46M
- 0.48× average
- Average volume
- 3.03M
- Average daily volume
- Market cap
- 46.59B JPY
- Beta
- 0.98
- Market reference 1
- 50-day average
- ¥351.4
- +3.59% above average
- 200-day average
- ¥426.04
- -14.56% below average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 59.23B JPY
- P/E (TTM)
- 10.44×
- P/B (TTM)
- 6.56×
- P/S (TTM)
- 4.28×
- EV / EBITDA
- 14.2×
- Earnings yield
- 6.76%
- Free cash flow yield
- 0.60%
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- 78.74%
- Operating margin
- 12.27%
- Net margin
- 38.17%
- Return on equity
- 61.15%
- Return on assets
- 42.43%
- Return on invested capital
- 17.95%
Financial health
- Debt / equity
- 0.09×
- Current ratio
- 3.11×
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (JPY) | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 10.89B JPY | 6.93B JPY | 4.59B JPY | 2.31B JPY | 1.51B JPY |
| Cost of goods sold | 2.31B JPY | 2.51B JPY | 1.5B JPY | 1.03B JPY | 845.22M JPY |
| Gross profit | 8.57B JPY | 4.42B JPY | 3.09B JPY | 1.29B JPY | 661.01M JPY |
| Research and development | 640.21M JPY | 498.2M JPY | 555.59M JPY | 451.54M JPY | 684.5M JPY |
| Selling, general, and administrative | 6.6B JPY | 5.08B JPY | 4.65B JPY | 4B JPY | 2.71B JPY |
| Operating expenses | 7.24B JPY | 5.58B JPY | 5.2B JPY | 4.45B JPY | 3.4B JPY |
| Interest income | 2.77M JPY | 598K JPY | 53K JPY | 101K JPY | 1.24M JPY |
| Interest expense | 18.01M JPY | 74.41M JPY | 83.76M JPY | 60.56M JPY | 4.78M JPY |
| Depreciation and amortization | 45K JPY | 1.16B JPY | 2.12B JPY | 3.16B JPY | 2.74B JPY |
| Operating income | 1.34B JPY | −1.16B JPY | −2.12B JPY | −3.16B JPY | −2.74B JPY |
| Net income | 4.16B JPY | −2.5B JPY | −255.51M JPY | −2.45B JPY | −1.89B JPY |
Company facts updated Aug 24, 2026.
Earnings
- Latest EPS result
- 14.71
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
7777.T peers
ETFs holding 7777.T
Funds reporting this stock among their holdings, ordered by reported position size.
Continue in GoAI
Research 7777.Tresearch.disclaimer






